Larvol Delta - AmMax-Bio-Announces-Positive-Interim-Phase-2-Results-of-AMB05X-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT

AMB-051 - AmMax

https://www.globenewswire.com/news-release/2021/10/20/2317344/0/en/AmMax-Bio-Announces-Positive-Interim-Phase-2-Results-of-AMB-05X-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT.html

Oct 20, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next